Shivaram Prasad Singh
Research Subjects
Shivaram Prasad Singh has a total of 578 co-authors. Here are the top co-authors by number of shared publications:
- Prajna Anirvan
Department of Gastroenterology, All India Institute of Medical Sciences, Bhubaneswar, India
19 shared publications - Manas Kumar Panigrahi
Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, 751019, India
12 shared publications Preetam Nath
Department of Gastroenterology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, 751024, India
9 shared publications- Ajay Duseja
Department of Hepatology, PGIMER, Chandigarh, India
8 shared publications Kaushal Madan
Max Centre for Gastroenterology, Hepatology and Endoscopy, Max Hospitals, Saket, New Delhi, India
8 shared publicationsAyaskanta Singh
Department of Gastroenterology, SUM Ultimate Medicare and SUM Hospital, Bhubaneswar, Odisha, 751003, India
7 shared publications
Latest Publications
- Open Access
ISG Task Force on Upper Gastrointestinal Bleeding (UGIB)—Comparison of Risk Scores in Nonvariceal Bleeding—A Prospective Multicenter Study
Background: To compare the performance of the Glasgow Blatchford score (GBS) to the Total Rockall score (TRS) in predicting clinical interventions in Indian patients with acute nonvariceal upper gastrointestinal bleeding (ANVUGIB). Materials and Methods: We prospectively studied ANVUGIB in 93 hospitals in India from October 2014 to September 2018. The etiological, clinical, and investigational details were recorded on a uniform structured proforma. The GBS and TRS were prospectively calculated for all patients. Clinical interventions were defined as blood transfusion, rebleed, and mortality with 30‐day follow‐up. Results: A total of 6450 patients with ANVUGIB were identified, followed up for 30 days and selected for analysis. Almost 5176 (80%) of the patients were male, and the mean age 50.7 ± 16.8 years (2–98 years). Blood transfusion was considered clinically necessary in 115 (1.7%) of the patients. Surgery and interventional radiology were required as rescue therapy in only 20 patients (0.3%) and 22 (0.3%) patients, respectively. The 30‐day rebleeding and mortality occurred in 92 (1.4%) and in 184 (2.8%) patients, respectively. GBS was similar to TRS in predicting mortality (AUC 0.687 vs. 0.663) with cutoff values of 10.5 and 3.5 and predicting rebleeding with (AUC 0.637 vs. 0.630) cutoff values of 11.5 and 3.5, respectively. Outcomes were defined as 30‐day mortality and rebleeding. Interventions were defined as transfusions, repeat endoscopy, surgery, or interventional radiology. Conclusions: GBS was more accurate and had more desirable clinical characteristics in predicting the need for a transfusion for hospitalized patients than TRS. However, both GBS and TRS have poor to modest predictive capability for 30‐day mortality and rebleeding. They do not, then, appear to be useful as screening tools to identify people at risk for those two outcomes in a hospital setting.
Open AccessISG Task Force on Upper Gastrointestinal Bleeding (UGIB)—Comparison of Risk Scores in Nonvariceal Bleeding—A Prospective Multicenter Study
Background: To compare the performance of the Glasgow Blatchford score (GBS) to the Total Rockall score (TRS) in predicting clinical interventions in Indian patients with acute nonvariceal upper gastrointestinal bleeding (ANVUGIB). Materials and Methods: We prospectively studied ANVUGIB in 93 hospitals in India from October 2014 to September 2018. The etiological, clinical, and investigational details were recorded on a uniform structured proforma. The GBS and TRS were prospectively calculated for all patients. Clinical interventions were defined as blood transfusion, rebleed, and mortality with 30‐day follow‐up. Results: A total of 6450 patients with ANVUGIB were identified, followed up for 30 days and selected for analysis. Almost 5176 (80%) of the patients were male, and the mean age 50.7 ± 16.8 years (2–98 years). Blood transfusion was considered clinically necessary in 115 (1.7%) of the patients. Surgery and interventional radiology were required as rescue therapy in only 20 patients (0.3%) and 22 (0.3%) patients, respectively. The 30‐day rebleeding and mortality occurred in 92 (1.4%) and in 184 (2.8%) patients, respectively. GBS was similar to TRS in predicting mortality (AUC 0.687 vs. 0.663) with cutoff values of 10.5 and 3.5 and predicting rebleeding with (AUC 0.637 vs. 0.630) cutoff values of 11.5 and 3.5, respectively. Outcomes were defined as 30‐day mortality and rebleeding. Interventions were defined as transfusions, repeat endoscopy, surgery, or interventional radiology. Conclusions: GBS was more accurate and had more desirable clinical characteristics in predicting the need for a transfusion for hospitalized patients than TRS. However, both GBS and TRS have poor to modest predictive capability for 30‐day mortality and rebleeding. They do not, then, appear to be useful as screening tools to identify people at risk for those two outcomes in a hospital setting.
- 27 July 2026
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 16 (6)
The Sirens of Precision Medicine in MASLD: Are We Sailing Beyond the Evidence?
- 27 July 2026
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 16 (6)
The Sirens of Precision Medicine in MASLD: Are We Sailing Beyond the Evidence?
- 1 June 2026
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 45 (6) , 1124-1136
A nationwide multi-centre survey of 12,500 cases of upper gastrointestinal bleeding: A report of Indian Society of Gastroenterology Task Force on acute upper gastrointestinal bleed
Background Upper gastrointestinal bleeding is an important gastrointestinal emergency medical condition; however, there is a lack of multi-centre national data on this condition for India. Hence, the Indian Society of Gastroenterology (ISG) constituted a task force on upper gastrointestinal bleeding (UGIB) to collect and create a database representative of every part of India. The aim of this pan-India multi-centre study was to determine the etiology and clinical characteristics of UGIB in India and to identify the risk factors that determine the overall outcome in these patients. Methods In consultation with the members of the task force, a protocol and case record form were developed and members of the ISG were invited to participate in data collection. Overall, 93 centres from different parts of India joined this study. A prospective longitudinal cohort study was designed and data was acquired between October 2014 and September 2018. All 93 participating centres were instructed to recruit patients with UGIB as per the approved protocol. All patients were followed up for 30 days either telephonically or during a hospital visit for re-bleeding rate up to 30 days from the first presentation, requirement for surgery and 30-day mortality. Statistical Package for the Social Sciences (SPSS) software (version 17.0, SPSS, Chicago, IL., USA) was used for all statistical analyses. Results Of 12,500 patients, 10,564 patients with UGIB were included in this study, 6450 (61.1%) and 4114 (38.9%) had non-variceal UGIB and variceal UGIB, respectively. Overall, 92 (1.4%) had rebleeding, 20 (0.3%) had surgery and 184 (2.8%) had mortality in non-variceal UGIB patients. Of variceal UGIB, 67 (1.6%) had rebleeding within 30 days, five (0.12%) variceal upper gastrointestinal bleeding (VUGIB) underwent surgery and 151 (3.67%) was the mortality rate among the VUGIB bleed. Conclusions This is the first large national database on patients with UGIB describing their causes, treatment outcomes, complications and predictors of complications. Graphical Abstract The alternative text for this image may have been generated using AI.
- 1 June 2026
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 45 (6) , 1124-1136
A nationwide multi-centre survey of 12,500 cases of upper gastrointestinal bleeding: A report of Indian Society of Gastroenterology Task Force on acute upper gastrointestinal bleed
Background Upper gastrointestinal bleeding is an important gastrointestinal emergency medical condition; however, there is a lack of multi-centre national data on this condition for India. Hence, the Indian Society of Gastroenterology (ISG) constituted a task force on upper gastrointestinal bleeding (UGIB) to collect and create a database representative of every part of India. The aim of this pan-India multi-centre study was to determine the etiology and clinical characteristics of UGIB in India and to identify the risk factors that determine the overall outcome in these patients. Methods In consultation with the members of the task force, a protocol and case record form were developed and members of the ISG were invited to participate in data collection. Overall, 93 centres from different parts of India joined this study. A prospective longitudinal cohort study was designed and data was acquired between October 2014 and September 2018. All 93 participating centres were instructed to recruit patients with UGIB as per the approved protocol. All patients were followed up for 30 days either telephonically or during a hospital visit for re-bleeding rate up to 30 days from the first presentation, requirement for surgery and 30-day mortality. Statistical Package for the Social Sciences (SPSS) software (version 17.0, SPSS, Chicago, IL., USA) was used for all statistical analyses. Results Of 12,500 patients, 10,564 patients with UGIB were included in this study, 6450 (61.1%) and 4114 (38.9%) had non-variceal UGIB and variceal UGIB, respectively. Overall, 92 (1.4%) had rebleeding, 20 (0.3%) had surgery and 184 (2.8%) had mortality in non-variceal UGIB patients. Of variceal UGIB, 67 (1.6%) had rebleeding within 30 days, five (0.12%) variceal upper gastrointestinal bleeding (VUGIB) underwent surgery and 151 (3.67%) was the mortality rate among the VUGIB bleed. Conclusions This is the first large national database on patients with UGIB describing their causes, treatment outcomes, complications and predictors of complications. Graphical Abstract The alternative text for this image may have been generated using AI.
- 7 January 2026
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 16 (2) , 103468
Type 2 Diabetes Mellitus and Risk of Advanced Fibrosis in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Results of Multi-centre Indian Consortium on MASLD (ICOM-D) Study
- 7 January 2026
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 16 (2) , 103468
Type 2 Diabetes Mellitus and Risk of Advanced Fibrosis in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Results of Multi-centre Indian Consortium on MASLD (ICOM-D) Study
- Open Access
- 17 July 2025
- Published by Xia & He Publishing in Journal of Translational Gastroenterology
- Vol. 000 (000) , 000
Admission Albumin-Bilirubin Score Is Inferior to MELD, MELD-Na + and Child-Turcotte-Pugh Score in Predicting Survival in Indian Patients with Alcohol-associated Liver Disease
Prognostic scores are valuable tools for predicting survival in patients with chronic liver disease. Recently, the albumin-bilirubin (ALBI) score has emerged as a potential prognostic indicator in liver-related conditions. This study aimed to compare the prognostic efficacy of the ALBI score with the Model for End-stage Liver Disease (MELD), MELD-Na+, and Child-Turcotte-Pugh (CTP) scores in predicting survival among patients with alcohol-associated liver disease (ALD).
- 17 July 2025
- Published by Xia & He Publishing in Journal of Translational Gastroenterology
- Vol. 000 (000) , 000
Open AccessAdmission Albumin-Bilirubin Score Is Inferior to MELD, MELD-Na + and Child-Turcotte-Pugh Score in Predicting Survival in Indian Patients with Alcohol-associated Liver Disease
Prognostic scores are valuable tools for predicting survival in patients with chronic liver disease. Recently, the albumin-bilirubin (ALBI) score has emerged as a potential prognostic indicator in liver-related conditions. This study aimed to compare the prognostic efficacy of the ALBI score with the Model for End-stage Liver Disease (MELD), MELD-Na+, and Child-Turcotte-Pugh (CTP) scores in predicting survival among patients with alcohol-associated liver disease (ALD).
- 22 May 2025
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 15 (6) , 102598
Lifestyle Intervention is Effective in Reversal of Fibrosis in NAFLD Patients: Results from a Retrospective Real-World Study
- 22 May 2025
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 15 (6) , 102598
Lifestyle Intervention is Effective in Reversal of Fibrosis in NAFLD Patients: Results from a Retrospective Real-World Study
- 16 May 2025
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 15 (5) , 102590
Adoption of the New Nomenclature of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by the Indian National Association for Study of the Liver (INASL): Implications for the INASL Guidance Paper on NAFLD
- 16 May 2025
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 15 (5) , 102590
Adoption of the New Nomenclature of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by the Indian National Association for Study of the Liver (INASL): Implications for the INASL Guidance Paper on NAFLD
- Open Access
- 20 March 2025
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 16 (01) , 024-028
Real-World Application of Shankhaprakshalana (a Yogic Technique) in Bowel Preparation for Colonoscopy in a Busy Outpatient Clinic: An External Validation Study
Achieving optimal bowel preparation is pivotal for successful colonoscopy. However, in the real-world scenario, this is challenging. A recent study by Panigrahi et al sheds light on Shankhaprakshalana (SP) as a promising method in achieving optimal bowel preparation before colonoscopy. Our primary aim was to evaluate the effectiveness of SP in the bustling environment of a real-world outpatient clinic.It was a prospective study conducted at Kalinga Gastroenterology Foundation, Cuttack, between May and August 2024. Patients requiring colonoscopy underwent bowel preparation by SP using the previously described methodology. Patients having poor performance status, diagnosed with bowel stricture and with history of abdominal surgery, and those unable to perform SP were excluded. Bowel preparation was assessed using Boston Bowel Preparation Scale (BBPS).SP was performed in 101 patients. The mean age of the patients was 43.57 (±13.54) years. The mean BBPS score was 8.6 (±0.7). Bowel preparation was adequate in all patients (100%). The mean segmental BBPS for the three segments of the colon (right, transverse, and left) were 2.8 (±0.3), 3.0 (±0.6), and 3.0 (±0.6), respectively. Bowel preparation was completed in 143 (±24) minutes, with an average of 6 (±2) motions. The cecal intubation time was 7 (±3) minutes and the median visual analog scale (VAS) score for patient-reported discomfort during colonoscopy was 0 (0–5). Ninety-seven percent of the patients were willing to repeat the procedure using SP.In a busy, outpatient setting, SP is an efficacious and highly acceptable bowel preparation regimen prior to colonoscopy.
- 20 March 2025
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 16 (01) , 024-028
Open AccessReal-World Application of Shankhaprakshalana (a Yogic Technique) in Bowel Preparation for Colonoscopy in a Busy Outpatient Clinic: An External Validation Study
Achieving optimal bowel preparation is pivotal for successful colonoscopy. However, in the real-world scenario, this is challenging. A recent study by Panigrahi et al sheds light on Shankhaprakshalana (SP) as a promising method in achieving optimal bowel preparation before colonoscopy. Our primary aim was to evaluate the effectiveness of SP in the bustling environment of a real-world outpatient clinic.It was a prospective study conducted at Kalinga Gastroenterology Foundation, Cuttack, between May and August 2024. Patients requiring colonoscopy underwent bowel preparation by SP using the previously described methodology. Patients having poor performance status, diagnosed with bowel stricture and with history of abdominal surgery, and those unable to perform SP were excluded. Bowel preparation was assessed using Boston Bowel Preparation Scale (BBPS).SP was performed in 101 patients. The mean age of the patients was 43.57 (±13.54) years. The mean BBPS score was 8.6 (±0.7). Bowel preparation was adequate in all patients (100%). The mean segmental BBPS for the three segments of the colon (right, transverse, and left) were 2.8 (±0.3), 3.0 (±0.6), and 3.0 (±0.6), respectively. Bowel preparation was completed in 143 (±24) minutes, with an average of 6 (±2) motions. The cecal intubation time was 7 (±3) minutes and the median visual analog scale (VAS) score for patient-reported discomfort during colonoscopy was 0 (0–5). Ninety-seven percent of the patients were willing to repeat the procedure using SP.In a busy, outpatient setting, SP is an efficacious and highly acceptable bowel preparation regimen prior to colonoscopy.
- 13 January 2025
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 15 (3) , 102503
Gut Microbiota and Genetic Polymorphisms Appear to Drive Disease Expression of Nonalcoholic Fatty Liver Disease in Lean Individuals
- 13 January 2025
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 15 (3) , 102503
Gut Microbiota and Genetic Polymorphisms Appear to Drive Disease Expression of Nonalcoholic Fatty Liver Disease in Lean Individuals
- 8 March 2024
- Published by Elsevier in Journal of Hepatology
- Vol. 81 (1) , e14-e15
Democratising the scientific method
- 8 March 2024
- Published by Elsevier in Journal of Hepatology
- Vol. 81 (1) , e14-e15
Democratising the scientific method